• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于贝叶斯网络的肝细胞癌肝切除术后生存预后因素分析

Analysis of prognostic factors for survival after hepatectomy for hepatocellular carcinoma based on a bayesian network.

作者信息

Cai Zhi-Qiang, Si Shu-Bin, Chen Chen, Zhao Yaling, Ma Yong-Yi, Wang Lin, Geng Zhi-Min

机构信息

Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University, College of Medicine, Xi'an 710061, Shaanxi, China; Department of Industrial Engineering, School of Mechanical Engineering, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China.

Department of Industrial Engineering, School of Mechanical Engineering, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China.

出版信息

PLoS One. 2015 Mar 31;10(3):e0120805. doi: 10.1371/journal.pone.0120805. eCollection 2015.

DOI:10.1371/journal.pone.0120805
PMID:25826337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4380349/
Abstract

BACKGROUND

The prognosis of hepatocellular carcinoma (HCC) after hepatectomy involves many factors. Previous studies have evaluated the separate influences of single factors; few have considered the combined influence of various factors. This paper combines the Bayesian network (BN) with importance measures to identify key factors that have significant effects on survival time.

METHODS

A dataset of 299 patients with HCC after hepatectomy was studied to establish a BN using a tree-augmented naïve Bayes algorithm that could mine relationships between factors. The composite importance measure was applied to rank the impact of factors on survival time.

RESULTS

124 patients (>10 months) and 77 patients (≤10 months) were correctly classified. The accuracy of BN model was 67.2%. For patients with long survival time (>10 months), the true-positive rate of the model was 83.22% and the false-positive rate was 48.67%. According to the model, the preoperative alpha fetoprotein (AFP) level and postoperative performance of transcatheter arterial chemoembolization (TACE) were independent factors for survival of HCC patients. The grade of preoperative liver function reflected the tendency for postoperative complications. Intraoperative blood loss, tumor size, portal vein tumor thrombosis (PVTT), time of clamping the porta hepatis, tumor number, operative method, and metastasis were dependent variables in survival time prediction. PVTT was considered the most significant for the prognosis of survival time.

CONCLUSIONS

Using the BN and importance measures, PVTT was identified as the most significant predictor of survival time for patients with HCC after hepatectomy.

摘要

背景

肝切除术后肝细胞癌(HCC)的预后涉及多种因素。以往研究评估了单一因素的单独影响;很少有研究考虑多种因素的综合影响。本文将贝叶斯网络(BN)与重要性度量相结合,以识别对生存时间有显著影响的关键因素。

方法

研究了299例肝切除术后HCC患者的数据集,使用树增强朴素贝叶斯算法建立BN,该算法可以挖掘因素之间的关系。应用综合重要性度量对因素对生存时间的影响进行排序。

结果

124例(>10个月)和77例(≤10个月)患者被正确分类。BN模型的准确率为67.2%。对于生存时间长(>10个月)的患者,模型的真阳性率为83.22%,假阳性率为48.67%。根据该模型,术前甲胎蛋白(AFP)水平和经动脉化疗栓塞术(TACE)的术后表现是HCC患者生存的独立因素。术前肝功能分级反映了术后并发症的发生趋势。术中出血量、肿瘤大小、门静脉癌栓(PVTT)、肝门阻断时间、肿瘤数量、手术方式和转移是生存时间预测中的因变量。PVTT被认为对生存时间的预后影响最大。

结论

使用BN和重要性度量,PVTT被确定为肝切除术后HCC患者生存时间的最显著预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/4380349/263fb70a0cd3/pone.0120805.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/4380349/f346c6f1499d/pone.0120805.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/4380349/2dc20378319a/pone.0120805.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/4380349/263fb70a0cd3/pone.0120805.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/4380349/f346c6f1499d/pone.0120805.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/4380349/2dc20378319a/pone.0120805.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/4380349/263fb70a0cd3/pone.0120805.g003.jpg

相似文献

1
Analysis of prognostic factors for survival after hepatectomy for hepatocellular carcinoma based on a bayesian network.基于贝叶斯网络的肝细胞癌肝切除术后生存预后因素分析
PLoS One. 2015 Mar 31;10(3):e0120805. doi: 10.1371/journal.pone.0120805. eCollection 2015.
2
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
3
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.术前经导管肝动脉化疗栓塞对肝细胞癌肝切除术后无病生存期的影响。
Cancer. 2000 Dec 15;89(12):2606-12.
4
[Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma].[影响≤3cm小肝细胞癌患者术后生存的预后因素]
Zhonghua Wai Ke Za Zhi. 2005 May 1;43(9):579-83.
5
Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.肝细胞癌合并门静脉癌栓的临床病理特征与手术疗效。
J Surg Res. 2012 Jun 15;175(2):243-50. doi: 10.1016/j.jss.2011.03.072. Epub 2011 Apr 24.
6
[Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases].[肝细胞癌肝移植:89例预后分析]
Zhonghua Wai Ke Za Zhi. 2005 Apr 1;43(7):450-4.
7
[Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].[经动脉化疗栓塞术单独及联合射频消融治疗肝细胞癌单支门静脉癌栓的安全性、疗效及预后因素比较]
Zhonghua Yi Xue Za Zhi. 2011 May 10;91(17):1167-72.
8
Survival factors after resection of small hepatocellular carcinoma.小肝细胞癌切除术后的生存因素。
Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):379-84.
9
[Impact of surgical operation-related factors on long-term survival of patients with hepatocellular carcinoma after hepatectomy].[手术相关因素对肝癌肝切除术后患者长期生存的影响]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):386-92.
10
Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌微血管侵犯、门静脉癌栓及切除术后生存不良的危险因素
Hepatogastroenterology. 2014 Sep;61(134):1696-703.

引用本文的文献

1
Comprehensive review of Bayesian network applications in gastrointestinal cancers.贝叶斯网络在胃肠道癌症中的应用综述
World J Clin Oncol. 2025 Jun 24;16(6):104299. doi: 10.5306/wjco.v16.i6.104299.
2
Survival path model outperforms conventional static machine learning models in long-term dynamic prognosis prediction for patients with intermediate stage hepatocellular carcinoma.生存路径模型在中期肝细胞癌患者的长期动态预后预测方面优于传统的静态机器学习模型。
Bioinform Adv. 2025 Feb 17;5(1):vbaf027. doi: 10.1093/bioadv/vbaf027. eCollection 2025.
3
Research progress on machine algorithm prediction of liver cancer prognosis after intervention therapy.

本文引用的文献

1
Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors.微血管侵犯并不能预测 2cm 以内的肝细胞癌的长期生存:对单发肿瘤分期系统的再评估。
Ann Surg Oncol. 2013 Apr;20(4):1223-9. doi: 10.1245/s10434-012-2739-y. Epub 2012 Nov 21.
2
Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis.替拉瑞韦和博赛匹韦治疗初治和经治慢性丙型肝炎 1 型患者的疗效:基于贝叶斯网络荟萃分析的间接比较。
Curr Med Res Opin. 2012 Nov;28(11):1841-56. doi: 10.1185/03007995.2012.734798. Epub 2012 Oct 31.
3
肝癌介入治疗后预后的机器算法预测研究进展
Am J Cancer Res. 2024 Sep 25;14(9):4580-4596. doi: 10.62347/BEAO1926. eCollection 2024.
4
Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study.体质指数是腹腔镜肝癌切除术术后发病率的一个风险因素:一项多中心回顾性研究。
J Cancer Res Clin Oncol. 2024 Oct 5;150(10):445. doi: 10.1007/s00432-024-05979-w.
5
Prediction model of gleason score upgrading after radical prostatectomy based on a bayesian network.基于贝叶斯网络的前列腺根治术后格里森评分升级预测模型。
BMC Urol. 2023 Oct 7;23(1):159. doi: 10.1186/s12894-023-01330-6.
6
Survival outcomes of the combination of extrafascial extrahepatic and extrafascial intrahepatic pedicle approaches in hepatectomy for hepatocellular carcinoma.肝外筋膜外与肝内筋膜外蒂入路联合在肝细胞癌肝切除术中的生存结局
Clin Exp Hepatol. 2022 Jun;8(2):147-152. doi: 10.5114/ceh.2022.116156. Epub 2022 May 26.
7
Dynamic Functional Continuous Time Bayesian Networks for Prediction and Monitoring of the Impact of Patients' Modifiable Lifestyle Behaviors on the Emergence of Multiple Chronic Conditions.用于预测和监测患者可改变生活方式行为对多种慢性病发生影响的动态功能连续时间贝叶斯网络
IEEE Access. 2021;9:169092-169106. doi: 10.1109/access.2021.3136618. Epub 2021 Dec 20.
8
Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?肝细胞癌治疗结果预测中机器学习的最新进展:我们应该了解什么?
Insights Imaging. 2021 Mar 6;12(1):31. doi: 10.1186/s13244-021-00977-9.
9
Supervised Machine Learning in Oncology: A Clinician's Guide.肿瘤学中的监督式机器学习:临床医生指南
Dig Dis Interv. 2020 Mar;4(1):73-81. doi: 10.1055/s-0040-1705097.
10
Summarizing Complex Graphical Models of Multiple Chronic Conditions Using the Second Eigenvalue of Graph Laplacian: Algorithm Development and Validation.使用图拉普拉斯算子的第二特征值总结多种慢性病的复杂图形模型:算法开发与验证
JMIR Med Inform. 2020 Jun 17;8(6):e16372. doi: 10.2196/16372.
Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.
干扰素调节因子(IRF)-1 和 IRF-2 与 HCC 的预后和肿瘤侵袭有关。
Ann Surg Oncol. 2013 Jan;20(1):267-76. doi: 10.1245/s10434-012-2487-z. Epub 2012 Jul 18.
4
Naïve Bayes QSDR classification based on spiral-graph Shannon entropies for protein biomarkers in human colon cancer.基于螺旋图香农熵的朴素贝叶斯QSDR分类用于人类结肠癌中的蛋白质生物标志物
Mol Biosyst. 2012 Jun;8(6):1716-22. doi: 10.1039/c2mb25039j. Epub 2012 Mar 30.
5
Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.中国单中心经验:复发性肝细胞癌患者再次肝切除的长期结果及复发类型分析和其预后。
Ann Surg Oncol. 2012 Aug;19(8):2515-25. doi: 10.1245/s10434-012-2269-7. Epub 2012 Mar 7.
6
Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study.经动脉化疗栓塞治疗不可切除伴门静脉癌栓的肝细胞癌:一项前瞻性对照研究。
Ann Surg Oncol. 2011 Feb;18(2):413-20. doi: 10.1245/s10434-010-1321-8. Epub 2010 Sep 14.
7
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.肝细胞癌合并门静脉癌栓的外科治疗。
Ann Surg Oncol. 2010 Aug;17(8):2073-80. doi: 10.1245/s10434-010-0940-4. Epub 2010 Feb 4.
8
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.亚洲肝细胞癌的管理:2009年亚洲肿瘤学峰会共识声明
Lancet Oncol. 2009 Nov;10(11):1111-8. doi: 10.1016/S1470-2045(09)70241-4.
9
Developing prognostic systems of cancer patients by ensemble clustering.通过集成聚类开发癌症患者的预后系统。
J Biomed Biotechnol. 2009;2009:632786. doi: 10.1155/2009/632786. Epub 2009 Jun 23.
10
Molecular mechanisms of hepatocellular carcinoma.肝细胞癌的分子机制
Hepatology. 2008 Dec;48(6):2047-63. doi: 10.1002/hep.22580.